Table 1.
Patient characteristics (n=42)
| Characteristics | Number of patients |
|---|---|
| Sex | |
| Male | 19 |
| Female | 23 |
| Age, years | |
| Median | 59.2 |
| Range | 31–66 |
| ECOG performance status | |
| 0 | 20 |
| 1 | 22 |
| ≥2 | 0 |
| Time since diagnosis (years), mean | 3.4 |
| Primary tumor type | |
| Colorectal cancer | 15 |
| Gastric cancer | 1 |
| Breast cancer | 1 |
| Esophageal cancer | 1 |
| Pancreatic cancer | 4 |
| NSCLC | 2 |
| Hepatocellular carcinoma | 2 |
| Prostate cancer | 1 |
| Other | 15 |
| Secondary tumor localization (%) | |
| Liver | 95 |
| Lung | 60 |
| Bone | 12 |
| Other | 25 |
| Prior therapy (%) | |
| Chemotherapy alone | 100 |
| Surgery | 69 |
| Chemotherapy and radiotherapy | 17 |
| Number of prior chemotherapy regimens (%) | |
| 1 | 7 |
| 2 | 52 |
| 3 | 36 |
| >3 | 5 |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; NSCLC, non-small-cell lung cancer.